Expert Outlook: Innovid Through The Eyes Of 5 Analysts
During the last three months, 5 analysts shared their evaluations of Innovid (NYSE:CTV), revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 2 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Innovid, revealing an average target of $2.82, a high estimate of $3.00, and a low estimate of $2.10. Witnessing a positive shift, the current average has risen by 14.63% from the previous average price target of $2.46.
Diving into Analyst Ratings: An In-Depth Exploration
A comprehensive examination of how financial experts perceive Innovid is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Andrew Boone | JMP Securities | Maintains | Market Outperform | $3.00 | $3.00 |
| Laura Martin | Needham | Maintains | Buy | $3.00 | $3.00 |
| Laura Martin | Needham | Raises | Buy | $3.00 | $2.25 |
| Brian Nowak | Morgan Stanley | Raises | Equal-Weight | $2.10 | $1.60 |
| Andrew Boone | JMP Securities | Maintains | Market Outperform | $3.00 | - |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Innovid. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Innovid compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Innovid's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Capture valuable insights into Innovid's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Innovid analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Get to Know Innovid Better
Innovid Corp is a software platform that provides ad serving, measurement and optimization creative services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV and desktop TV environments to advertisers, publishers and media agencies. It is engaged in ad serving, measurement and creative services. It operates in U.S., Canada, EMEA, APAC and LATAM, out of which it derives maximum revenue from U.S.
Innovid's Financial Performance
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Innovid displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 20.51%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Communication Services sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -16.97%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Innovid's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -3.2%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Innovid's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -2.56%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Innovid's debt-to-equity ratio is below the industry average. With a ratio of 0.06, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: What Are They?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.